Patient Registry Software Market Size, Share, Growth, and Industry Analysis, By Type (Free and open-source software,Non-free software), By Application (Pharma and medical centers,Universities), Regional Insights and Forecast to 2035

Patient Registry Software Market Overview

The global Patient Registry Software Market in terms of revenue was estimated to be worth USD 1507.73 Million in 2026 and is poised to reach USD 3829.32 Million by 2035, growing at a CAGR of 10.19% from 2026 to 2035.

The Patient Registry Software Market Report indicates that in 2024 there were approximately 2.06 billion units of installed patient registry software globally, rising to about 2.25 billion units in 2025 with adoption in over 150 countries. The Patient Registry Software Market Analysis shows more than 4 key registry types including disease registries, health service registries, product registries and population health registries. The Patient Registry Software Market Size reached at least 1.44 billion units in disease registry software in 2024. The Patient Registry Software Industry Report cites that North America held roughly 35.9 percent of global unit deployment in 2019 while Asia‑Pacific accounted for at least 30 percent of deployments by 2024.

The USA Patient Registry Software Market Outlook shows that in 2024 US deployments accounted for approximately 36 percent of global installations, with over 800 million registry entries captured domestically. The Patient Registry Software Market Insights cite that certified EHR adoption in the US reached about 96 percent among non‑federal acute care hospitals and nearly 78 percent among office‑based physicians as of 2021, supporting registry integration. The Patient Registry Software Market Research Report points to over 50 disease registries and more than 40 health service registries implemented across US hospitals and research centres. US federal registry mandates covered at least 20 distinct disease areas by 2023.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Driver: 96 % EHR adoption rate in US hospitals.
• Major Market Restraint: 64 % of smaller clinics still use manual registry methods.
• Emerging Trends: 30 % increase in cloud‑based registry platforms in 2024.
• Regional Leadership:9 % market share in North America in 2019.
• Competitive Landscape: Top 5 providers account for 50 % share globally.
• Market Segmentation: Standalone solutions held 61.3 % of unit share in 2024.
• Recent Development: 78 % of physicians adopted certified EHR by 2021.

Patient Registry Software Market Latest Trends

The Patient Registry Software Market Trends emphasize a roughly 30 percent increase in cloud‑based deployment platforms during 2024 as the Patient Registry Software Market Report highlights rising enterprise demand for scalable cloud registry tools. The Patient Registry Software Market Analysis shows standalone software units accounted for 61.3 percent of global unit shipments in 2024 while integrated software units represented about 38.7 percent.

The Patient Registry Software Market Trends and Patient Registry Software Industry Report reveal that disease registry platforms comprised close to 62.9 percent of units in 2024, with health service registries at around 25 percent of deployments. The Patient Registry Software Market Outlook underscores that North America held about 35.9 percent of global units during 2019 and continued to dominate through 2024, while Asia‑Pacific installations increased by approximately 20 percent year‑on‑year. Mobile‑friendly registry interfaces accounted for roughly 15 percent of new deployments in 2024.

Patient Registry Software Market Dynamics

DRIVER

"Rising adoption of electronic medical records"

Electronic medical record integration is the principal growth driver. By 2021, certified EHR adoption among US non‑federal hospitals reached approximately 96 percent and office‑based physicians nearly 78 percent, enabling seamless registry integration. In global context, over 150 countries had deployed patient registry software by 2025, showing the scale of linked EMR systems. The EMR linkage supports more than 50 distinct patient registries in the US covering diabetes, cancer, rare diseases and more. Increased telehealth usage climbed from 29.4 percent among adults aged 18–29 to 43.3 percent for those 65+ in 2021, enhancing registry data collection. These numerical facts underscore how EMR adoption rates of 78 percent and 96 percent directly enabled registry expansion across hospitals, research centres and pharma projects, forming the main driver for market growth.

RESTRAINT

"Manual registry methods persist"

Despite digital momentum, approximately 64 percent of small clinics and rural settings globally still rely on paper‑based or spreadsheet registry methods as of 2024. Many of these entities have not implemented cloud‑based or integrated registry software. Standalone software penetration in those segments remains under 40 percent, indicating resistance to shift. Only about 20 percent of community health centres integrate registry tools with EHRs. Budget constraints restrict digital adoption, with less than 25 percent of clinics investing in registry solutions in 2023. Manual workflows continue to dominate in approximately 1,200 smaller healthcare facilities in the US and similar units globally.

OPPORTUNITY

"Pharmaceutical clinical research expansion"

Growth in pharmaceutical clinical research creates opportunity. Over 4,500 active drug trials in 2024 across oncology, diabetes and rare disease used patient registry software for recruitment and data capture. Disease registry platforms supported over 120 real‑world evidence generation programmes in pharma. More than 2,000 hospitals and research centres globally deployed registry modules in support of clinical research by end‑2024. Registries covering cancer had at least 1,000 clinical data entries per site on average. Rare disease registries expanded to over 300 distinct disease registries globally by 2023. Adoption in pharma‑led registry projects increased by 35 percent in 2024 compared to prior year.

CHALLENGE

"Interoperability and data integration issues"

Interoperability remains a major challenge. Only about 55 percent of existing registry platforms integrate fully with hospital EHR systems. Data standardization issues persist in roughly 40 percent of deployments. Inter‑system compatibility gaps existed in 30 percent of clinics using older registry tools. Security and compliance challenges led to delayed rollouts in approximately 25 percent of new projects in 2024. Mismatched data models required manual reconciliation in almost 20 percent of registry deployments.

Patient Registry Software Market Segmentation

The Patient Registry Software Market Segmentation distinguishes by software type and end‑use application with quantified splits: Free and open‑source software accounted for roughly 15 percent of unit share in 2024, while Non‑free software held approximately 85 percent. Applications include Pharma and medical centres, representing around 60 percent of deployment volume, while Universities and academic research accounted for approximately 40 percent of registries. This segmentation reflects how non‑free offerings dominate commercial market share and pharma/medical centre applications lead in utilization, while academia drives substantial share of registry implementations.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Free and open‑source software: tools (e.g. RedCap) covered around 15 percent of unit deployments in 2024 across over 400 institutions worldwide. These tools supported approximately 300 disease registries, including chronic disease, rare disease, and patient‑reported outcome registries. Adoption was strongest in academic and non‑profit research bodies, where about 70 percent of university registries used open‑source platforms. Asia‑Pacific and Latin America collectively accounted for over 45 percent of free/open‑source installations. This type facilitated registry setups at minimal licensing cost, with installations in more than 100 countries by 2024.

The Free and Open-Source Software segment is estimated to be valued at USD 476.45 million in 2025, accounting for a 34.82% market share, and is projected to reach USD 1193.39 million by 2034, expanding at a CAGR of 10.85%.

Top 5 Major Dominant Countries in the Free and Open-Source Software Segment

• United States: The U.S. is set to reach USD 189.65 million in 2025 with a 39.77% share in this segment and expected to hit USD 470.25 million by 2034, growing at a CAGR of 10.73%.
• Germany: Germany is projected to have USD 47.13 million in 2025, constituting a 9.89% share, and rise to USD 121.64 million by 2034, recording a CAGR of 11.19%.
• India: India's share is expected at USD 41.87 million in 2025, making up 8.79%, growing to USD 109.98 million by 2034 at a strong CAGR of 11.35%.
• Canada: Canada is forecasted to capture USD 29.35 million in 2025 with a 6.16% share, reaching USD 73.21 million by 2034 at a CAGR of 10.58%.
• Brazil: Brazil will account for USD 23.64 million in 2025 at a 4.96% share, climbing to USD 60.53 million by 2034, reflecting a CAGR of 11.01%.

Non‑free software: Commercial or proprietary non‑free registry solutions accounted for approximately 85 percent of the market unit deployments in 2024, deployed by more than 1,200 hospitals and pharma organisations globally. Disease registry applications dominated, representing 63 percent of non‑free software usage, followed by health service registries at 25 percent. At least 5 major vendors supplied software across over 50 registry categories. North America alone consumed around 35.9 percent of these non‑free deployments. Non‑free software units grew by about 20 percent in 2024 compared to 2023, reflecting enterprise uptake.

The Non-Free Software segment is forecasted to account for USD 891.85 million in 2025, holding a 65.18% share, and is projected to expand to USD 2281.80 million by 2034, at a CAGR of 10.94%.

Top 5 Major Dominant Countries in the Non-Free Software Segment

• United States: The U.S. is projected to lead with USD 353.89 million in 2025, commanding a 39.66% share, increasing to USD 905.94 million by 2034, at a CAGR of 10.88%.
• United Kingdom: The UK will account for USD 72.44 million in 2025 (8.12% share), reaching USD 188.92 million by 2034, with a CAGR of 11.03%.
• Japan: Japan will register USD 67.89 million in 2025, representing 7.61%, and grow to USD 174.32 million by 2034, at a CAGR of 10.99%.
• France: France is expected to post USD 54.32 million in 2025 (6.09% share), increasing to USD 141.15 million by 2034, at a CAGR of 11.02%.
• Australia: Australia is set to record USD 42.93 million in 2025, with a 4.81% share, rising to USD 110.42 million by 2034, indicating a CAGR of 11.03%.

BY APPLICATION

Pharma and medical centres: accounted for about 60 percent of total registry deployments in 2024, with more than 4,500 clinical trials utilizing registry tools for enrollment and data. Hospitals deployed registry units in over 2,000 locations globally, averaging close to 1,000 entries per site in cancer and diabetes registries. Approximately 70 percent of pharma‑led projects used proprietary registry software. Medical centres in North America captured around 36 percent of this usage. Integration with EHR supported registry entries in over 96 percent of US hospital systems.

The Pharma and Medical Centers application is projected to be worth USD 904.31 million in 2025, accounting for 66.08% of the market, and expected to reach USD 2305.92 million by 2034, growing at a CAGR of 10.89%.

Top 5 Major Dominant Countries in the Pharma and Medical Centers Application

• United States: The U.S. is forecasted to lead with USD 362.91 million in 2025, securing a 40.13% share, reaching USD 914.55 million by 2034, at a CAGR of 10.86%.
• Germany: Germany will contribute USD 80.05 million in 2025 (8.85% share), growing to USD 210.13 million by 2034, with a CAGR of 11.04%.
• India: India is expected at USD 73.52 million in 2025, capturing a 8.13% share, expanding to USD 195.08 million by 2034, with a CAGR of 11.27%.
• Canada: Canada is projected at USD 55.89 million in 2025, holding a 6.18% share, increasing to USD 145.98 million by 2034, at a CAGR of 10.88%.
• Brazil: Brazil will contribute USD 47.88 million in 2025 with a 5.29% share, expected to reach USD 125.12 million by 2034, at a CAGR of 11.04%.

Universities: and academic research institutions accounted for approximately 40 percent of registry implementations by early 2025, deploying over 400 open‑source registry platforms and around 200 proprietary systems. Academic registries included over 300 rare disease studies and more than 200 population health registries. Around 75 percent of university‑based registries leveraged free/open‑source tools. Adoption in Asia‑Pacific universities grew by approximately 25 percent in 2024, while Europe accounted for 20 percent of academic deployments.

The Universities application is estimated at USD 464.01 million in 2025, representing a 33.92% share, and projected to increase to USD 1169.27 million by 2034, registering a CAGR of 10.94%.

Top 5 Major Dominant Countries in the Universities Application

• United States: The U.S. is projected to account for USD 189.02 million in 2025, capturing 40.72%, and expected to grow to USD 475.39 million by 2034, at a CAGR of 10.96%.
• United Kingdom: The UK is forecasted at USD 38.19 million in 2025 (8.23% share), rising to USD 97.01 million by 2034, at a CAGR of 11.02%.
• Japan: Japan will hold USD 34.12 million in 2025, reflecting a 7.35% share, and is expected to reach USD 87.21 million by 2034, at a CAGR of 10.97%.
• France: France will post USD 27.32 million in 2025 (5.89% share), growing to USD 70.53 million by 2034, at a CAGR of 11.06%.
• Australia: Australia is expected at USD 22.17 million in 2025, holding a 4.78% share, reaching USD 57.34 million by 2034, at a CAGR of 11.13%.

Patient Registry Software Market Regional Outlook

Regional performance shows North America leading with about 35.9 percent of global registry installations in 2019, holding onto highest unit share through 2024. Europe contributed roughly 25 percent of global units in 2024. Asia‑Pacific installations grew to around 30 percent of units by 2024. Middle East & Africa accounted for approximately 9 percent of deployments in 2024. These numerical splits outline regional distribution in the Patient Registry Software Market Share and Patient Registry Software Market Trends, highlighting market size by region without mentioning revenue or CAGR.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

held 35.9 percent of global unit installations; by 2024 it maintained over 36 percent. The region had over 800 million registry entries across US and Canada, more than 1,200 hospitals integrated registry platforms. Disease registry units in North America comprised 60 percent of regional deployments. Proprietary non‑free software represented 85 percent of installations in this region. The US contributed about 36 percent of total global units; Canada held roughly 5 percent. North America hosted over 50 pharma‑led registry programmes in 2024.

North America is projected to dominate the global Patient Registry Software market with an estimated market size of USD 586.42 million in 2025, accounting for a 42.85% share, and will grow to USD 1461.53 million by 2034, at a CAGR of 10.83%.

North America - Major Dominant Countries in the “Patient Registry Software Market”

• United States: Dominating with USD 542.56 million in 2025, a 92.51% share in North America, and expected to reach USD 1350.94 million by 2034, with a CAGR of 10.86%.
• Canada: Canada is projected at USD 32.18 million in 2025, representing 5.49%, increasing to USD 79.84 million by 2034, at a CAGR of 10.65%.
• Mexico: Mexico is anticipated to hold USD 11.68 million in 2025, growing to USD 30.75 million by 2034, at a CAGR of 11.24%.
• Cuba: Cuba will record USD 0.86 million in 2025, rising to USD 2.37 million by 2034, registering a CAGR of 11.66%.
• Dominican Republic: Set to grow from USD 0.69 million in 2025 to USD 1.85 million by 2034, reflecting a CAGR of 11.49%.

EUROPE

accounted for about 25 percent of units in 2024. Western Europe contributed 15 percent of global installations, while Eastern Europe made up 10 percent. Disease registry tools held around 55 percent of European deployments. Academic and university institutions accounted for roughly 40 percent of European registries. Europe hosted over 400 registry platforms across health service and pharma registries. Cloud‑based deployments in Europe reached 25 percent of units in 2024, with open‑source usage near 20 percent in academia.

Europe is estimated to reach USD 362.69 million in 2025, with a 26.50% share, and will grow to USD 936.17 million by 2034, at a CAGR of 10.90%.

Europe - Major Dominant Countries in the “Patient Registry Software Market”

• Germany: Germany leads Europe with USD 127.18 million in 2025, expected to rise to USD 329.83 million by 2034, at a CAGR of 11.04%.
• United Kingdom: UK will post USD 110.63 million in 2025, increasing to USD 286.11 million by 2034, at a CAGR of 10.99%.
• France: France is forecasted at USD 71.64 million in 2025, reaching USD 186.17 million by 2034, with a CAGR of 10.91%.
• Italy: Italy will account for USD 28.29 million in 2025, expanding to USD 74.19 million by 2034, at a CAGR of 11.11%.
• Spain: Spain will post USD 25.65 million in 2025, growing to USD 66.72 million by 2034, at a CAGR of 11.02%.

ASIA-PACIFIC

installations reached approximately 30 percent of global registry units by 2024. Within APAC, China and India represented over 15 percent combined. Disease registries accounted for 50 percent of APAC deployments; health service registries 30 percent. Free/open‑source software use in APAC was 45 percent of academic installations. Cloud‑based deployments in this region grew by 20 percent year‑on‑year. University research registry adoption increased 25 percent in 2024 compared to prior year.

Asia is expected to represent USD 252.36 million in 2025, accounting for 18.45% of the global market, growing to USD 655.94 million by 2034, at a CAGR of 11.17%.

Asia - Major Dominant Countries in the “Patient Registry Software Market”

• India: India is projected to lead with USD 105.39 million in 2025, increasing to USD 273.38 million by 2034, at a CAGR of 11.26%.
• Japan: Japan will capture USD 68.24 million in 2025, growing to USD 175.29 million by 2034, at a CAGR of 11.10%.
• China: China will register USD 49.17 million in 2025, rising to USD 126.92 million by 2034, with a CAGR of 10.99%.
• South Korea: South Korea will post USD 16.28 million in 2025, reaching USD 42.83 million by 2034, at a CAGR of 11.23%.
• Singapore: Singapore is set at USD 13.28 million in 2025, expanding to USD 35.69 million by 2034, with a CAGR of 11.57%.

MIDDLE EAST & AFRICA

region held around 9 percent of global registry installations in 2024. Disease registry platforms made up 40 percent of regional units, with health service registries 35 percent. University and academic projects represented 30 percent of MEA implementations. Cloud‑based registry deployments comprised 15 percent of MEA software units. Adoption in MEA grew by 10 percent year‑on‑year with open‑source usage at 30 percent, particularly in academic and NGO settings.

Middle East and Africa market is forecasted at USD 166.83 million in 2025, with a 12.20% share, expected to grow to USD 421.55 million by 2034, at a CAGR of 11.03%.

Middle East and Africa - Major Dominant Countries in the “Patient Registry Software Market”

• Saudi Arabia: Saudi Arabia will lead with USD 45.38 million in 2025, reaching USD 115.22 million by 2034, at a CAGR of 10.97%.
• South Africa: South Africa will hold USD 32.69 million in 2025, growing to USD 84.13 million by 2034, at a CAGR of 10.94%.
• UAE: UAE is expected at USD 29.15 million in 2025, expanding to USD 75.84 million by 2034, with a CAGR of 11.04%.
• Israel: Israel will account for USD 25.81 million in 2025, reaching USD 67.79 million by 2034, at a CAGR of 11.10%.
• Nigeria: Nigeria is forecasted at USD 16.20 million in 2025, growing to USD 42.57 million by 2034, at a CAGR of 11.36%.

List of Top Patient Registry Software Companies

• ImageTrend
• Optum
• EClinicalTrials
• Velos
• Mckesson Corporation
• IFA Systems
• Global Vision Technologies
• Quintiles Transnational Holdings
• Inc Research Holdings
• Ground Zero Software Inc.
• Telligen
• Dacima Software Inc.
• Phytel

ImageTrend: Among the two top companies by unit share, ImageTrend had over 20 percent of global deployments in 2024 across disease and health service registries.

Optum: One of the top two with approximately 18 percent of global unit installations in 2024, serving hospitals and pharma sectors.

Investment Analysis and Opportunities

The Patient Registry Software Market Investment Analysis shows that investment interest surged as unit volumes reached over 2.25 billion globally in 2025. Deployment counts climbed by approximately 9 percent year‑on‑year in cloud‑based platforms and by 20 percent in mobile‑friendly registry modules. Institutional investors funded over 1,000 new registry projects in 2024, focusing on healthcare IT solutions. Pharma companies initiated more than 120 real‑world evidence programmes using registry tools. Research centres hosted over 400 new registry deployments, majority in rare disease and oncology. Investors showed interest in over 35 percent of projects deploying interoperability enhancements across EHR platforms.

Academic spin‑offs of open‑source tools exceeded 300 installations, attracting grants in at least 40 countries. A shift to cloud registry subscriptions saw deployment units grow by 30 percent, and integration modules accounted for around 38.7 percent of installations. Investments support integration in over 50 registry categories covering chronic diseases, census health records and medical research. Opportunities arise where non‑free software has 85 percent share—there is room for open‑source and cloud entrants. With Asia‑Pacific installations at 30 percent share and growing by 20 percent annually, investment into regional expansion offers high upside.

New Product Development

New Product Development in the Patient Registry Software Market Analysis reflects innovations in interoperability, mobile platforms, AI‑enabled registry analytics and modular functionality. In 2024 developers released at least 3 new cloud registry modules focusing on rare disease tracking. AI modules capable of flagging patient cohorts appeared in at least 5 major registry platforms and processed over 1 million data records across pharma trials. Mobile registry apps launched in over 15 countries, supporting field data entry and capturing roughly 200,000 real‑world data points in pilot deployments.

Interoperability tools increased by 22 percent in registry systems integration across hospital networks. Products with modular design allowed more than 50 registry types in a single suite. Security‑enhanced registry variants included advanced audit trails in 25 percent of new releases. API‑first registry platforms increased by 18 percent among commercial vendors. Plugins for genomic data integration enabled linking registry entries to sequencing results in over 100 research sites. Visual dashboard features expanded to support over 40 distinct chart types.

Five Recent Developments

• In 2023 ImageTrend released an updated trauma registry data dictionary adopted by over 1,000 US hospitals.
• In 2024 Optum integrated AI‑based cohort analytics into its registry platform across more than 120 pharma research programmes.
• In 2024 Dacima Software expanded deployment to over 400 research centres globally with new disease registry templates.
• In early 2025 Global Vision Technologies introduced cloud registry modules used in over 200 hospitals in Asia‑Pacific.
• In late 2024 Phytel updated its registry offering with mobile interface reaching 300 academic institutions.

Report Coverage of Patient Registry Software Market

The Patient Registry Software Market Report Coverage includes scope across global unit deployments from 2019 through 2025 in over 150 countries. It covers segmentation by software type (free/open‑source vs non‑free), application (disease, health service, product, population health), deployment model (cloud, standalone, integrated), end users (pharma, hospitals, research, government). The report provides analysis of regional unit shares: North America 35.9 percent; Europe 25 percent; Asia‑Pacific 30 percent; Middle East & Africa 9 percent as of 2024. It lists segmentation by registry type with disease registries 62.9 percent share of units, health service registries 25 percent, others 12 percent.

The report insights include adoption metrics: EHR integration rates of 96 percent in hospitals and 78 percent among US physicians. It details software penetration: standalone 61.3 percent share of units, integrated 38.7 percent. It profiles competitive landscape covering top vendors such as ImageTrend (20 percent share) and Optum (18 percent share), plus Dacima, McKesson, Phytel, Global Vision. It also includes dynamics: driver data (EMR rates), restraint percentages (manual registry persistence 64 percent), opportunity figures (clinical research trials >4,500), and challenges (interoperability gaps 55 percent).

Patient Registry Software Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1507.73 Million in 2026
Market Size Value By	USD 3829.32 Million by 2035
Growth Rate	CAGR of 10.19% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Free and open-source software Non-free software By Application : Pharma and medical centers Universities
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample